ID   SYDC_HUMAN              Reviewed;         501 AA.
AC   P14868; A8K3J2; D3DP77; Q2TNI3; Q32Q69; Q53HV4; Q53YC5; Q68CR9;
AC   Q9BW52;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   10-MAY-2017, entry version 181.
DE   RecName: Full=Aspartate--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.12;
DE   AltName: Full=Aspartyl-tRNA synthetase;
DE            Short=AspRS;
DE   AltName: Full=Cell proliferation-inducing gene 40 protein;
GN   Name=DARS; ORFNames=PIG40;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2674137;
RA   Jacobo-Molina A., Peterson R., Yang D.C.H.;
RT   "cDNA sequence, predicted primary structure, and evolving amphiphilic
RT   helix of human aspartyl-tRNA synthetase.";
RL   J. Biol. Chem. 264:16608-16612(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kim J.W.;
RT   "Identification of a cell proliferation-inducing gene.";
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adipose tissue;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Embryo;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH KARS.
RX   PubMed=18029264; DOI=10.1016/j.bbrc.2007.11.028;
RA   Guzzo C.M., Yang D.C.H.;
RT   "Lysyl-tRNA synthetase interacts with EF1alpha, aspartyl-tRNA
RT   synthetase and p38 in vitro.";
RL   Biochem. Biophys. Res. Commun. 365:718-723(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-74 AND LYS-374, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   TISSUE SPECIFICITY, AND VARIANTS HBSL LEU-256; VAL-274; TYR-367;
RP   HIS-460; LEU-464; CYS-487; CYS-494 AND GLY-494.
RX   PubMed=23643384; DOI=10.1016/j.ajhg.2013.04.006;
RA   Taft R.J., Vanderver A., Leventer R.J., Damiani S.A., Simons C.,
RA   Grimmond S.M., Miller D., Schmidt J., Lockhart P.J., Pope K., Ru K.,
RA   Crawford J., Rosser T., de Coo I.F., Juneja M., Verma I.C.,
RA   Prabhakar P., Blaser S., Raiman J., Pouwels P.J., Bevova M.R.,
RA   Abbink T.E., van der Knaap M.S., Wolf N.I.;
RT   "Mutations in DARS cause hypomyelination with brain stem and spinal
RT   cord involvement and leg spasticity.";
RL   Am. J. Hum. Genet. 92:774-780(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-52 AND SER-249, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Catalyzes the specific attachment of an amino acid to
CC       its cognate tRNA in a 2 step reaction: the amino acid (AA) is
CC       first activated by ATP to form AA-AMP and then transferred to the
CC       acceptor end of the tRNA.
CC   -!- CATALYTIC ACTIVITY: ATP + L-aspartate + tRNA(Asp) = AMP +
CC       diphosphate + L-aspartyl-tRNA(Asp).
CC   -!- SUBUNIT: Homodimer; also part of a multisubunit complex that
CC       groups AIMP1, AIMP2, EEF1A1 and tRNA ligases for Arg, Asp, Glu,
CC       Gln, Ile, Leu, Lys, Met and Pro.
CC   -!- INTERACTION:
CC       Q13155:AIMP2; NbExp=11; IntAct=EBI-358730, EBI-745226;
CC       Q08050:FOXM1; NbExp=2; IntAct=EBI-358730, EBI-866480;
CC       P62993:GRB2; NbExp=2; IntAct=EBI-358730, EBI-401755;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P14868-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P14868-2; Sequence=VSP_056192;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expression in the developing and adult brain
CC       shows similar patterns. Highly expressed in the ventricular and
CC       subventricular zones, including hippocampal subfields, the
CC       midlateral temporaal cortex and the frontal polar cortex. The
CC       cerebellum, cereral cortex, hippocampus, and lateral ventricle
CC       show preferential neuronal expression. Expression in the
CC       peripheral neurons is evident in the colon.
CC       {ECO:0000269|PubMed:23643384}.
CC   -!- DISEASE: Hypomyelination with brainstem and spinal cord
CC       involvement and leg spasticity (HBSL) [MIM:615281]: An autosomal
CC       recessive leukoencephalopathy characterized by onset in the first
CC       year of life of severe spasticity, mainly affecting the lower
CC       limbs and resulting in an inability to achieve independent
CC       ambulation. Affected individuals show delayed motor development
CC       and nystagmus; some may have mild mental retardation. Brain MRI
CC       shows hypomyelination and white matter lesions in the cerebrum,
CC       brainstem, cerebellum, and spinal cord.
CC       {ECO:0000269|PubMed:23643384}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase
CC       family. Type 2 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05032; AAA35567.1; -; mRNA.
DR   EMBL; AY762100; AAX07827.1; -; mRNA.
DR   EMBL; BT006710; AAP35356.1; -; mRNA.
DR   EMBL; AK290607; BAF83296.1; -; mRNA.
DR   EMBL; AK222476; BAD96196.1; -; mRNA.
DR   EMBL; CR749809; CAH18669.1; -; mRNA.
DR   EMBL; AC011999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093391; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11617.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11620.1; -; Genomic_DNA.
DR   EMBL; BC000629; AAH00629.1; -; mRNA.
DR   EMBL; BC107749; AAI07750.1; -; mRNA.
DR   CCDS; CCDS2180.1; -. [P14868-1]
DR   PIR; A34393; SYHUDT.
DR   RefSeq; NP_001280241.1; NM_001293312.1. [P14868-2]
DR   RefSeq; NP_001340.2; NM_001349.3. [P14868-1]
DR   UniGene; Hs.503787; -.
DR   UniGene; Hs.595819; -.
DR   PDB; 4J15; X-ray; 2.24 A; A/B=1-501.
DR   PDBsum; 4J15; -.
DR   ProteinModelPortal; P14868; -.
DR   SMR; P14868; -.
DR   BioGrid; 107984; 84.
DR   IntAct; P14868; 24.
DR   MINT; MINT-141082; -.
DR   STRING; 9606.ENSP00000264161; -.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   iPTMnet; P14868; -.
DR   PhosphoSitePlus; P14868; -.
DR   SwissPalm; P14868; -.
DR   BioMuta; DARS; -.
DR   DMDM; 20178330; -.
DR   OGP; P14868; -.
DR   REPRODUCTION-2DPAGE; IPI00216951; -.
DR   EPD; P14868; -.
DR   MaxQB; P14868; -.
DR   PaxDb; P14868; -.
DR   PeptideAtlas; P14868; -.
DR   PRIDE; P14868; -.
DR   DNASU; 1615; -.
DR   Ensembl; ENST00000264161; ENSP00000264161; ENSG00000115866. [P14868-1]
DR   GeneID; 1615; -.
DR   KEGG; hsa:1615; -.
DR   UCSC; uc002tux.2; human. [P14868-1]
DR   CTD; 1615; -.
DR   DisGeNET; 1615; -.
DR   GeneCards; DARS; -.
DR   HGNC; HGNC:2678; DARS.
DR   HPA; HPA020451; -.
DR   HPA; HPA029804; -.
DR   HPA; HPA029805; -.
DR   MalaCards; DARS; -.
DR   MIM; 603084; gene.
DR   MIM; 615281; phenotype.
DR   neXtProt; NX_P14868; -.
DR   OpenTargets; ENSG00000115866; -.
DR   Orphanet; 363412; Hypomyelination with brain stem and spinal cord involvement and leg spasticity.
DR   PharmGKB; PA27146; -.
DR   eggNOG; KOG0556; Eukaryota.
DR   eggNOG; COG0017; LUCA.
DR   GeneTree; ENSGT00550000074880; -.
DR   HOVERGEN; HBG001028; -.
DR   InParanoid; P14868; -.
DR   KO; K01876; -.
DR   OMA; WGDDLST; -.
DR   OrthoDB; EOG091G0530; -.
DR   PhylomeDB; P14868; -.
DR   TreeFam; TF105676; -.
DR   BRENDA; 6.1.1.12; 2681.
DR   Reactome; R-HSA-2408517; SeMet incorporation into proteins.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   ChiTaRS; DARS; human.
DR   GeneWiki; DARS_(gene); -.
DR   GenomeRNAi; 1615; -.
DR   PRO; PR:P14868; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115866; -.
DR   CleanEx; HS_DARS; -.
DR   ExpressionAtlas; P14868; baseline and differential.
DR   Genevisible; P14868; HS.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0004046; F:aminoacylase activity; TAS:ProtInc.
DR   GO; GO:0004815; F:aspartate-tRNA ligase activity; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006422; P:aspartyl-tRNA aminoacylation; TAS:ProtInc.
DR   GO; GO:0006461; P:protein complex assembly; TAS:ProtInc.
DR   GO; GO:0006412; P:translation; TAS:ProtInc.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   HAMAP; MF_02075; Asp_tRNA_synth_type2; 1.
DR   InterPro; IPR004364; aa-tRNA-synt_II.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR004523; Asp-tRNA_synthase_2.
DR   InterPro; IPR002312; Asp/Asn-tRNA-synth_IIb.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR004365; NA-bd_OB_tRNA.
DR   Pfam; PF00152; tRNA-synt_2; 1.
DR   Pfam; PF01336; tRNA_anti-codon; 1.
DR   PRINTS; PR01042; TRNASYNTHASP.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   TIGRFAMs; TIGR00458; aspS_nondisc; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Complete proteome; Cytoplasm;
KW   Disease mutation; Ligase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Protein biosynthesis; Reference proteome.
FT   CHAIN         1    501       Aspartate--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000111010.
FT   NP_BIND     273    275       ATP. {ECO:0000250}.
FT   NP_BIND     281    283       ATP. {ECO:0000250}.
FT   NP_BIND     472    475       ATP. {ECO:0000250}.
FT   REGION      251    254       Aspartate. {ECO:0000250}.
FT   REGION      411    415       Binding site for the 3'-end of tRNA.
FT                                {ECO:0000255}.
FT   BINDING     229    229       Aspartate. {ECO:0000250}.
FT   BINDING     273    273       Aspartate. {ECO:0000250}.
FT   BINDING     424    424       ATP. {ECO:0000250}.
FT   BINDING     427    427       Aspartate. {ECO:0000250}.
FT   BINDING     431    431       Aspartate. {ECO:0000250}.
FT   MOD_RES      52     52       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      74     74       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     249    249       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     374    374       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     500    500       Phosphothreonine; by PKA. {ECO:0000255}.
FT   VAR_SEQ       1    100       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_056192.
FT   VARIANT     256    256       M -> L (in HBSL).
FT                                {ECO:0000269|PubMed:23643384}.
FT                                /FTId=VAR_070038.
FT   VARIANT     274    274       A -> V (in HBSL; dbSNP:rs369152939).
FT                                {ECO:0000269|PubMed:23643384}.
FT                                /FTId=VAR_070039.
FT   VARIANT     367    367       D -> Y (in HBSL; dbSNP:rs370064817).
FT                                {ECO:0000269|PubMed:23643384}.
FT                                /FTId=VAR_070040.
FT   VARIANT     426    426       L -> F (in dbSNP:rs1803165).
FT                                /FTId=VAR_027611.
FT   VARIANT     460    460       R -> H (in HBSL; dbSNP:rs587776985).
FT                                {ECO:0000269|PubMed:23643384}.
FT                                /FTId=VAR_070041.
FT   VARIANT     464    464       P -> L (in HBSL; dbSNP:rs148806569).
FT                                {ECO:0000269|PubMed:23643384}.
FT                                /FTId=VAR_070042.
FT   VARIANT     487    487       R -> C (in HBSL; dbSNP:rs587776984).
FT                                {ECO:0000269|PubMed:23643384}.
FT                                /FTId=VAR_070043.
FT   VARIANT     494    494       R -> C (in HBSL; dbSNP:rs147077598).
FT                                {ECO:0000269|PubMed:23643384}.
FT                                /FTId=VAR_070044.
FT   VARIANT     494    494       R -> G (in HBSL; dbSNP:rs147077598).
FT                                {ECO:0000269|PubMed:23643384}.
FT                                /FTId=VAR_070045.
FT   CONFLICT      5      7       SAS -> TQ (in Ref. 1; AAA35567).
FT                                {ECO:0000305}.
FT   CONFLICT     31     31       I -> T (in Ref. 9; AAI07750).
FT                                {ECO:0000305}.
FT   CONFLICT     38     38       Q -> H (in Ref. 5; BAD96196).
FT                                {ECO:0000305}.
FT   CONFLICT    164    164       A -> Q (in Ref. 1; AAA35567).
FT                                {ECO:0000305}.
FT   CONFLICT    312    312       Q -> H (in Ref. 2; AAX07827).
FT                                {ECO:0000305}.
FT   CONFLICT    414    414       N -> K (in Ref. 1; AAA35567).
FT                                {ECO:0000305}.
FT   CONFLICT    447    447       I -> N (in Ref. 1; AAA35567).
FT                                {ECO:0000305}.
FT   HELIX        26     28       {ECO:0000244|PDB:4J15}.
FT   STRAND       29     31       {ECO:0000244|PDB:4J15}.
FT   HELIX        48     50       {ECO:0000244|PDB:4J15}.
FT   HELIX        53     55       {ECO:0000244|PDB:4J15}.
FT   STRAND       59     72       {ECO:0000244|PDB:4J15}.
FT   STRAND       75     82       {ECO:0000244|PDB:4J15}.
FT   STRAND       85     93       {ECO:0000244|PDB:4J15}.
FT   TURN         94     96       {ECO:0000244|PDB:4J15}.
FT   HELIX        99    107       {ECO:0000244|PDB:4J15}.
FT   STRAND      113    122       {ECO:0000244|PDB:4J15}.
FT   STRAND      134    146       {ECO:0000244|PDB:4J15}.
FT   HELIX       156    160       {ECO:0000244|PDB:4J15}.
FT   HELIX       176    181       {ECO:0000244|PDB:4J15}.
FT   HELIX       183    186       {ECO:0000244|PDB:4J15}.
FT   HELIX       190    212       {ECO:0000244|PDB:4J15}.
FT   HELIX       250    259       {ECO:0000244|PDB:4J15}.
FT   STRAND      264    271       {ECO:0000244|PDB:4J15}.
FT   STRAND      286    294       {ECO:0000244|PDB:4J15}.
FT   HELIX       300    320       {ECO:0000244|PDB:4J15}.
FT   HELIX       322    331       {ECO:0000244|PDB:4J15}.
FT   STRAND      344    347       {ECO:0000244|PDB:4J15}.
FT   HELIX       348    357       {ECO:0000244|PDB:4J15}.
FT   HELIX       370    384       {ECO:0000244|PDB:4J15}.
FT   STRAND      387    392       {ECO:0000244|PDB:4J15}.
FT   HELIX       396    398       {ECO:0000244|PDB:4J15}.
FT   STRAND      407    409       {ECO:0000244|PDB:4J15}.
FT   STRAND      412    420       {ECO:0000244|PDB:4J15}.
FT   STRAND      423    431       {ECO:0000244|PDB:4J15}.
FT   HELIX       435    444       {ECO:0000244|PDB:4J15}.
FT   HELIX       450    452       {ECO:0000244|PDB:4J15}.
FT   HELIX       453    457       {ECO:0000244|PDB:4J15}.
FT   TURN        458    461       {ECO:0000244|PDB:4J15}.
FT   STRAND      466    472       {ECO:0000244|PDB:4J15}.
FT   HELIX       473    481       {ECO:0000244|PDB:4J15}.
FT   HELIX       486    489       {ECO:0000244|PDB:4J15}.
SQ   SEQUENCE   501 AA;  57136 MW;  B181572DF0AF5F94 CRC64;
     MPSASASRKS QEKPREIMDA AEDYAKERYG ISSMIQSQEK PDRVLVRVRD LTIQKADEVV
     WVRARVHTSR AKGKQCFLVL RQQQFNVQAL VAVGDHASKQ MVKFAANINK ESIVDVEGVV
     RKVNQKIGSC TQQDVELHVQ KIYVISLAEP RLPLQLDDAV RPEAEGEEEG RATVNQDTRL
     DNRVIDLRTS TSQAVFRLQS GICHLFRETL INKGFVEIQT PKIISAASEG GANVFTVSYF
     KNNAYLAQSP QLYKQMCICA DFEKVFSIGP VFRAEDSNTH RHLTEFVGLD IEMAFNYHYH
     EVMEEIADTM VQIFKGLQER FQTEIQTVNK QFPCEPFKFL EPTLRLEYCE ALAMLREAGV
     EMGDEDDLST PNEKLLGHLV KEKYDTDFYI LDKYPLAVRP FYTMPDPRNP KQSNSYDMFM
     RGEEILSGAQ RIHDPQLLTE RALHHGIDLE KIKAYIDSFR FGAPPHAGGG IGLERVTMLF
     LGLHNVRQTS MFPRDPKRLT P
//
